The Cigna Group (NYSE:CI) Stock Holdings Trimmed by 44 Wealth Management LLC

44 Wealth Management LLC reduced its position in The Cigna Group (NYSE:CI) by 18.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,128 shares of the health services provider’s stock after selling 471 shares during the quarter. 44 Wealth Management LLC’s holdings in The Cigna Group were worth $588,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Oxbow Advisors LLC increased its position in The Cigna Group by 17.5% in the 4th quarter. Oxbow Advisors LLC now owns 19,188 shares of the health services provider’s stock valued at $5,299,000 after acquiring an additional 2,855 shares during the period. Deseret Mutual Benefit Administrators boosted its stake in shares of The Cigna Group by 6.5% during the 4th quarter. Deseret Mutual Benefit Administrators now owns 800 shares of the health services provider’s stock worth $221,000 after acquiring an additional 49 shares in the last quarter. Hudson Edge Investment Partners Inc. boosted its stake in shares of The Cigna Group by 1.9% during the 4th quarter. Hudson Edge Investment Partners Inc. now owns 1,883 shares of the health services provider’s stock worth $520,000 after acquiring an additional 36 shares in the last quarter. Paradigm Asset Management Co. LLC boosted its stake in shares of The Cigna Group by 74.1% during the 4th quarter. Paradigm Asset Management Co. LLC now owns 5,875 shares of the health services provider’s stock worth $1,622,000 after acquiring an additional 2,500 shares in the last quarter. Finally, Waterfront Wealth Inc. boosted its stake in shares of The Cigna Group by 36.4% during the 4th quarter. Waterfront Wealth Inc. now owns 3,406 shares of the health services provider’s stock worth $940,000 after acquiring an additional 909 shares in the last quarter. 86.99% of the stock is owned by institutional investors.

The Cigna Group Price Performance

CI opened at $299.92 on Friday. The Cigna Group has a one year low of $262.03 and a one year high of $370.83. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.66 and a quick ratio of 0.72. The company’s 50 day simple moving average is $286.35 and its 200-day simple moving average is $319.60. The stock has a market capitalization of $83.42 billion, a P/E ratio of 24.50, a price-to-earnings-growth ratio of 0.98 and a beta of 0.54.

The Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, January 30th. The health services provider reported $6.64 earnings per share for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same quarter last year, the business earned $6.79 earnings per share. Sell-side analysts anticipate that The Cigna Group will post 29.77 earnings per share for the current fiscal year.

The Cigna Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, March 20th. Shareholders of record on Wednesday, March 5th will be issued a $1.51 dividend. The ex-dividend date is Wednesday, March 5th. This is a positive change from The Cigna Group’s previous quarterly dividend of $1.40. This represents a $6.04 annualized dividend and a yield of 2.01%. The Cigna Group’s dividend payout ratio (DPR) is 45.75%.

Analyst Ratings Changes

CI has been the subject of several research reports. Barclays reduced their price objective on The Cigna Group from $420.00 to $339.00 and set an “overweight” rating for the company in a research note on Friday, January 31st. Piper Sandler reissued an “overweight” rating and issued a $348.00 price objective (down from $394.00) on shares of The Cigna Group in a research note on Monday, February 3rd. StockNews.com raised The Cigna Group from a “hold” rating to a “buy” rating in a research note on Wednesday. Morgan Stanley decreased their target price on shares of The Cigna Group from $403.00 to $379.00 and set an “overweight” rating for the company in a research note on Friday, January 31st. Finally, Wells Fargo & Company lowered their price target on The Cigna Group from $370.00 to $341.00 and set an “equal weight” rating for the company in a research note on Tuesday, February 4th. Two research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Buy” and a consensus price target of $373.69.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.